FDA Adverse Event Injury Summary report: N

BIOVENTUS EXOGEN 4000J MOU ASSEMBLY

MDR report key: 3775761 · Received April 25, 2014

Report

Report Number
3010203571-2014-00001
Event Type
Injury
Date Received
April 25, 2014
Date of Event
March 11, 2014
Report Date
April 16, 2014
Manufacturer
BIOVENTUS LLC
Product Code
LOF
PMA / PMN Number
P900009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

ACCORDING TO THE TREATING PHYSICIAN, THIS EVENT IS SERIOUS AND RELATED TO THE USE OF EXOGEN. A MEDICAL REVIEW WAS PERFORMED BY BOTH (B)(4) AND BIOVENTUS. NONE AGREES THAT THIS INCIDENT IS RELATED TO THE DEVICE. SKIN ULCERS MIGHT OCCUR DUE TO COMPONENTS OF THE CAST OR TAPE SUCH AS TRAPPED HUMIDITY UNDER THE TAPE OR CAST. THE EXOGEN ULTRASOUND DEVICE SIGNAL IS TOO WEAK TO CAUSE ANY SKIN OR TISSUE DAMAGE. THE PACKAGE INSERT OF THIS DEVICE STATES THAT THE UNIT SHOULD BE USED UNDER OBSERVATION DURING TREATMENT FOR OPERATIVE WOUNDS AND EXTERNAL WOUNDS. IF SKIN TROUBLE IS RECOGNIZED THEN THE PT MUST STOP USING THE DEVICE.

Description of Event or Problem · 1

AVERSE EVENT: CUTANEOUS ULCER. PER (B)(4), THE PRESCRIBING PHYSICIAN RECOGNIZED A CUTANEOUS ULCER WHEN HE REMOVED THE MEDICAL TAPE FROM THE PATIENT'S AFFECTED AREA (LEFT HUMERUS). THE PT WAS TREATING HER LEFT HUMERUS WITH EXOGEN DEVICE. NO MALFUNCTION OF THE DEVICE WAS REPORTED AS TREATMENT IS STILL CONTINUING WITH NO TROUBLE. ADVERSE EVENT: CUTANEOUS ULCER. PER (B)(4), THE PRESCRIBING PHYSICIAN RECOGNIZED A CUTANEOUS ULCER WHEN HE REMOVED THAT MEDICAL TAPE FROM THE PATIENT'S AFFECTED AREA (LEFT HUMERUS). THE PT WAS TREATING HER LEFT HUMERUS WITH EXOGEN DEVICE. THE DOCTOR RECOGNIZED THE WOUND HEALING ON (B)(6) 2014. NO MALFUNCTION OF THE DEVICE WAS REPORTED AS TREATMENT IS STILL CONTINUING WITH NO TROUBLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
252335 BIOVENTUS EXOGEN 4000J MOU ASSEMBLY BONE GROWTH STIMULATOR LOF BIOVENTUS LLC UNK UNK

Patients

Seq Age Sex Outcome Treatment
1 23 YR Other